Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reduction decrease » reduction decreased (Expand Search), reduction reuse (Expand Search), production increases (Expand Search)
occurs » occur (Expand Search)
Showing 41 - 60 results of 14,220 for search '(( significant reduction decrease ) OR ( significant decrease occurs ))', query time: 0.60s Refine Results
  1. 41
    Switching patterns of ICS/LABA.

    Switching patterns of ICS/LABA. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 42
    Factors associated with exacerbations.

    Factors associated with exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 43
    Definition of each exacerbation.

    Definition of each exacerbation. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 44
    Definitions of treatment step classification.

    Definitions of treatment step classification. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 45
    Sensitivity analyses of breakthrough exacerbations.

    Sensitivity analyses of breakthrough exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 46
    Baseline characteristics of patients.

    Baseline characteristics of patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 47
    Data for primary and sensitivity analysis.

    Data for primary and sensitivity analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 48
    Study design.

    Study design. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 49
    Odds ratios for each case period compared with the control period.

    Odds ratios for each case period compared with the control period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 50
    Sensitivity analysis of the group who had an exacerbation before the index date.

    Sensitivity analysis of the group who had an exacerbation before the index date. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 51
    Initial post-switch visits and SABA prescriptions in each period.

    Initial post-switch visits and SABA prescriptions in each period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 52
    Flow of eligible patients.

    Flow of eligible patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 53
    ICS/LABA before and after switch.

    ICS/LABA before and after switch. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 54
    Diseases excluded from the analysis.

    Diseases excluded from the analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 55
    Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells.

    Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. by Courtney A. Swain (15170264)

    Published 2025
    Save to List
    Saved in:
  16. 56
    APRIL<sup>-/-</sup> and BLyS<sup>-/-</sup> lymphocyte proliferation significantly decreased when challenged with alloantigen.

    APRIL<sup>-/-</sup> and BLyS<sup>-/-</sup> lymphocyte proliferation significantly decreased when challenged with alloantigen. by Natalie M. Bath (6316517)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 57
    The impact of various treatment regimens on SW480 tumour reduction in BALB/C nude mice is evident.

    The impact of various treatment regimens on SW480 tumour reduction in BALB/C nude mice is evident. by Zhi Xuan Low (19270163)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 58
    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States.

    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States. by Zian Zafar Cheema (22446246)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Census Regions in the United States.

    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Census Regions in the United States. by Zian Zafar Cheema (22446246)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Overall population and Sex in the United States.

    Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Overall population and Sex in the United States. by Zian Zafar Cheema (22446246)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: